An Exercise Facilitator to Activate Simple Training Programs in the Dialysis Center
An Exercise Facilitator to Break Down the Barriers to Physical Activity of End-stage Kidney Disease Patients. A Pragmatic Implementation Trial in a Nephrology Unit
1 other identifier
interventional
144
1 country
1
Brief Summary
Low physical activity levels and progressive poor functional capacity affect quality of life and clinical outcomes of Chronic Kidney Disease (CKD) patients. Interventions to prevent the functional decline associated with a sedentary lifestyle or to relief from deconditioning are crucial, considering the significant beneficial effects of exercise in all CKD patients, especially in End-stage Kidney Disease patients (ESKD). Unfortunately, physical and psychological barriers to exercise are present and physical activity management is not routinely addressed in the patient's care. For the first time the project aims to test the impact of the regular presence of an exercise specialist in the Nephrology Unit. This facilitator, evaluating capacity, motivation and preferences of each patient, will design tailored solutions and assess the related outcomes. Several design of training programs will be proposed to dialysis patients, that can choose the exercise option that best fits their needing. The study will determine the feasibility of the project, the patients' adherence and the effectiveness of the programs proposed to improve the patients' lifestyle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2020
CompletedFirst Posted
Study publicly available on registry
February 25, 2020
CompletedStudy Start
First participant enrolled
February 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedAugust 11, 2025
May 1, 2025
4.8 years
February 3, 2020
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6-minute walking test (Mobility)
Subjects will be instructed to walk as far as possible on a 22m walkway in 6 minutes, with their habitual walking device, with the possibility to slow down and rest if necessary. The total distance walked, the pain-free walking distance, and the perceived exertion at the end of the test will be recorded.
Change at 3-month (end of training) respect to baseline
Secondary Outcomes (12)
10-meter walking test (gait speed)
Change at 3-month (end of training) respect to baseline
5-time sit-to-stand test (lower limbs strength)
Change at 3-month (end of training) respect to baseline
Short Form Health Survey (SF-36) (health-related quality of life)
Change at 3-month (end of training) respect to baseline
Short Falls Efficacy Scale (sFES) (fear of falling)
Change at 3-month (end of training) respect to baseline
Duke Activity Status Index (DASI) (Estimated functional capacity)
Change at 3-month (end of training) respect to baseline
- +7 more secondary outcomes
Study Arms (4)
Home-based unstructured physical activity program
EXPERIMENTALAccording to each patient's baseline physical activity level, the facilitator will advise patients to start or to increase their spontaneous activity by giving counselling on total exercise time, mode, intensity and frequency as suggested by the American College of Sport Medicine guidelines. Every patient will be provided with a log-book and a wearable physical activity monitor, which has to be returned in the subsequent controls, to favor adherence and objectively measure the exercise activities
Home-based structured low-intensity physical activity program
EXPERIMENTALAccording to each patient's baseline physical activity level, a semi-personalized walking program, will be provided. This program, derived from previous experience on renal patients, includes a 10-min session/day of intermittent walking (1- or 2-min work and 1-min seated rest) to be performed at home at prescribed speed. The speed, converted into walking cadence and followed by a metronome, is weekly increased. Patients will be provided with a daily log containing the detailed exercise prescription and spaces to give a feedback on training execution and related symptoms.
In-hospital structured supervised physical activity program
EXPERIMENTALPatients will join the room properly equipped for the exercise program in groups of maximum four subjects for a 2-time/week thirty minutes training sessions, to be performed for dialysis patients immediately before or after the dialysis treatment, or in non-dialysis according to their preferences. Each sessions will include low-intensity walking exercises (similar to the structured home-based training), resistance and power exercises with elastic bands and light weights. Each sessions will begin and end with a warm-up and cool-down period of stretching. The total duration of the session will be about 30 minutes. Rate of perceived exertion will be collected and the training intensity will be set according to the patient's baseline capacity and weekly increased.
No-training
NO INTERVENTIONPatients choosing this option will not start any physical activity program, but they will perform the outcome measures, acting as a control group.
Interventions
Counselling on physical activity according to American College of Sports Medicine guidelines
Structured home-based low-intensity intermittent walking program
Supervised exercise training program
Eligibility Criteria
You may qualify if:
- male and females aged \> 18 years;
- ability to walk assisted or unassisted at least for 6 meters;
- cognitive functioning to give informed consent identified by a Mini Mental Status Examination score ≥18/30.
You may not qualify if:
- severe cardio-respiratory (e.g. unstable angina; severe heart failure identified by New York Heart Association class III or IV);
- neurological or musculoskeletal conditions (e.g. above knee amputation) contraindicating or inhibiting exercise training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital of Ferraralead
- Università degli Studi di Ferraracollaborator
Study Sites (1)
University Hospital of Ferrara
Ferrara, 44124, Italy
Related Publications (1)
Manfredini F, Lamberti N, Battaglia Y, Straudi S, Belvederi Murri M, Donadi M, Piva G, Fabbian F, Lopez-Soto PJ, Grassi L, Manfredini R, Basaglia N, Storari A. A Personalized Patient-Centered Intervention to Empower through Physical Activity the Patient in the Dialysis Center: Study Protocol for a Pragmatic Nonrandomized Clinical Trial. Methods Protoc. 2020 Dec 6;3(4):83. doi: 10.3390/mps3040083.
PMID: 33470990DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fabio Manfredini, MD
University of Ferrara and University Hospital of Ferrara
- PRINCIPAL INVESTIGATOR
Alda Storari, MD
University Hospital of Ferrara
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome measures assessors will be blinded to group allocation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2020
First Posted
February 25, 2020
Study Start
February 26, 2020
Primary Completion
December 31, 2024
Study Completion
February 28, 2025
Last Updated
August 11, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Study protocol will be available upon acceptance by a peer-reviewed journal. IPD will be available beginning 6 months following study results publication.
- Access Criteria
- Anyone who wishes to access the data.
Individual participant data that underlie the results published at the end of the trial after deidentification. The database of the study will be published in a public repository.